Preparation and characterization of a cocrystalline suspension of [Lys(B28),Pro(B29)]-human insulin analogue

Journal of Pharmaceutical Sciences

Volumn 87, Issue 2, 1998, Pages 170-176

  Defelippis, Michael R ^a   Bakaysa, Diane L ^a   Bell, Maureen A ^a   Heady, Mark A ^a   Li, Shun ^a   Pye, Susan ^b   Youngman, Karen M ^c   Radziuk, Jerry ^b   Frank, Bruce H ^a  

^a ELI LILLY AND COMPANY   (United States)

^b UNIVERSITY OF OTTAWA   (Canada)

^c UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN DERIVATIVE; INSULIN LISPRO; ISOPHANE INSULIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CRYSTALLIZATION; DIABETES MELLITUS; DOG; DOSE TIME EFFECT RELATION; DRUG ABSORPTION; DRUG FORMULATION; DRUG SOLUBILITY; GLUCOSE HOMEOSTASIS; INSULIN TREATMENT; NONHUMAN; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031914344     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js970285m     Document Type: Article

References (21)

1. Anderson, J. L.; Patterson, E.; Conlon, M.; Pasyk, S.; Pitt, B.; Lucchesi, B. R. Kinetics of antifibrillatory effects of bretylium: correlation with myocardial drug concentrations. Am. J. Cardiol. 1980, 46, 583-592.
2. Gillis, A. M.; Kates, R. E. Myocardial uptake kinetics and pharmacodynamics of propafenone in the isolated perfused rabbit heart. J. Pharmacol. Exp. Ther. 1986, 237, 708-712.
3. Horowitz, J. D.; Dynon, M. K.; Woodward, E.; Sia, S. T. B.; Macdonald, P. S.; Morgan, D. J.; Goble, A. J.; Louis, W. J. Short-term myocardial uptake of lidocaine and mexiletine in patients with ischemic heart disease. Circulation 1986, 73, 987-996.
4. Powell, A. C.; Horowitz, J. D.; Kertes, P. J.; Hasin, Y.; Syrjanen, M. L.; Henry, C. A.; Sartor, D. M.; Louis, W. J. Determinants of acute hemodynamic and electrophysiologic effects of verapamil in humans: role of myocardial drug uptake. J. Cardiovasc. Pharmacol. 1990, 16, 572-583.
5. Gillis, A. M.; Keashly, R. Influence of hypoxia on the myocardial uptake and pharmacodynamics of quinidine in isolated perfused rabbit hearts. J. Cardiovasc. Pharmacol. 1991, 17, 249-255.
6. Powell, A. C.; Horowitz, J. D.; Hasin, Y.; Syrjanen, M. L.; Horomidis, S.; Louis, W. J. Acute myocardial uptake of digoxin in humans: correlation with hemodynamic and electrocardiographic effects. J. Am. Coll. Cardiol. 1990, 15, 1238-1247.
7. Ritchie, R. H.; Wuttke, R. D.; Stafford, I.; Horowitz, J. D. Relation between acute myocardial uptake and hemodynamic and electrocardiographic effects of metoprolol in humans. J. Cardiovasc. Pharmacol. 1994, 23, 57-65.
8. Ritchie, R. H.; Sallustio, B. C.; Hii, J. T. Y.; Horowitz, J. D. Acute myocardial uptake of d-and l-sotalol in humans. Relation to hemodynamicand electrophysiologic effects. J. Cardiovasc. Pharmacol. In press.
9. Ganz, W.; Tamura, K.; Marcua, H. S.; Donoso, R.; Yoshida, S.; Swan, H. J. C. Measurement of coronary sinus blood flow by continuous thermodilution in man. Circulation 1971, 44, 181-185.
10. Unadkat, J. D.; Bartha, F.; Sheiner, L. B. Simultaneous modeling of pharmacokinetics and pharmacodynamics with nonparametric kinetic and dynamic models. Clin. Pharmacol. Ther. 1986, 40, 86-93.
11. Wagner, J. G. Fundamentals of Clinical Pharmacokinetics; Drug Intelligence Publications: Hamilton, Il, 1975.
12. Holford, N. H. G.; Sheiner, L. B. Understanding the dose -effect relationship: clinical application of pharmacokinetic-pharmacodynamic models. Clin. Pharmacokinet. 1981, 6, 429-453.
13. Yamaoka, K.; Nakagawa, T.; Uno, T. Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. J. Pharmacokinet. Biopharm. 1978, 6, 165-175.
14. Charbonneau, P.; Syrota, A.; Crouzel, C.; Velois, J. M.; Prenant, C.; Crouzel, M. Peripheral-type benzodiazepine receptors in the living heart characterized by positron emission tomography. Circulation 1986, 73, 476-483.
15. Jogestrand T. Digoxin concentration in right atrial myocardium, skeletal muscle and serum in man: influence of atrial rhythm. Eur. J. Clin. Pharmacol. 1980, 17, 243-250.
16. Latini, R.; Cavalli, A.; Maggioni, A. P.; Volpi, A. Flecainide distribution in human tissues. Br. J. Clin. Pharmacol. 1987, 24, 820-822.
17. Dayneka, N. L.; Garg, V.; Jusko, W. J. Comparison of four basic models of indirect pharmacodynamic responses. J. Pharmacokinet. Biopharm. 1993, 21, 457-478.
18. Sheiner, L. B.; Stanski, D. R.; Vozeh, S.; Miller, R. D.; Ham, J. H. Simultaneous modeling of pharmacokinetics and pharmacodynamics: Application to d-tubocurarine. Clin. Pharmacol. Ther. 1979, 25, 358-371.
19. Bortolotti, A.; Castelli, D.; Verotta, D.; Bonati, M. Pharmacokinetic and pharmacodynamic modelling of metoprolol in rabbits with liver failure. Eur. J. Drug. Metab. Pharmacokinet. 1989, 14, 145-151.
20. Braat, M. C. P.; Jonkers, R. E.; van Boxtel, C. J. Quantification of metoprolol beta 2-adrenoceptor antagonism in asthmatic patients by pharmacokinetic-pharmacodynamic modelling. Pulm. Pharmacol. 1992, 5, 31-38.
21. Anttila, M.; Arstila, M.; Pfeffer, M.; Tikkanen, R.; Vallinkorski, V.; Sundquist, H. Human pharmacokinetics of sotalol. Acta Pharmacol. Toxicol. 1976, 39, 118-128.